PolymarketVerfügbarkeit prüfenKein KYC2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle implizite Wahrscheinlichkeit
December 31, 68%+1.0pt
Marktqualitat
67 / 100
Mittlere Qualität24h-Volumen
2209 €
Liquidität
17.386,8 €
Mittlere LiquiditätGeld / Brief
67.0% / 68.0%
Spread
1.0 pt
Enger SpreadComments
0
Marktdaten
Aktualisiert vor 7 Minuten
19. Aug. 26, 17:4931. Dez. 27, 23:59
Trends
Regeln
This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- Intismeran autogene refers to the individualized neoantigen therapy developed by Moderna and Merck and evaluated in the Phase 3 INTerpath-001 trial (NCT05933577), also known as mRNA-4157 and V940, together with any brand, trade, or nonproprietary name later assigned to that product, as well as any renamed or modified version that the relevant company or the FDA identify as the same product or a direct continuation of the V940/mRNA-4157 program.
- Differences in neoantigen composition between patients will not affect resolution.
- Changes to the product's formulation will not affect resolution, provided the FDA approves the product described above.
- Approval as part of a combination regimen will qualify.
Offene Märkte
Health & MedicinePOLYMARKETSkin cancer vaccine BLA submitted by June 30, 2027?
- Yes+1.0pt87.1%
- No-1.0pt12.9%
- Gesamtvolumen
- 32.531,3 €
- 24h-Volumen
- 15.425,1 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+0.1pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 15.014,2 €
POLYMARKETHantavirus pandemic in 2026?
- No+0.1pt97%
- Yes-0.1pt3%
- Gesamtvolumen
- 15,3 Mio. €
- 24h-Volumen
- 8886,9 €
KALSHIMeasles cases in 2026?
- Above 3000-1.0pt96%
- Above 4000-1.0pt81%
- Above 6000+5.0pt29%
+2 weitere Ergebnisse
- Gesamtvolumen
- 782.253,8 €
POLYMARKETHeidi Overton confirmed as FDA Commissioner by which date?
- December 3172%
- October 3133%
- November 3033%
+1 weitere Ergebnisse
- Gesamtvolumen
- 6513,9 €
KALSHIWhen will Heidi Overton be confirmed as Commissioner of the FDA?
- Before Aug 1, 202774%
- Before Apr 1, 202767%
- Before Jan 1, 202767%
+2 weitere Ergebnisse
- Gesamtvolumen
- 4487,1 €
- 24h-Volumen
- 3674,5 €
- Will 3 mg THC beverages qualify as hemp under federal law?
- New pandemic in 2026?
- Measles cases in U.S. by August 31?
- How many human screwworm cases will be reported in the United States in 2026?
- Which countries will report an Ebola disease case before October?
- Hantavirus vaccine in 2026?
- Ebola pandemic in 2026?
- FDA decision: Brepocitinib by Priovant Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
Häufige Fragen
- Wie stehen die aktuellen Quoten für FDA approves skin cancer vaccine by which date??
- Polymarket bewertet December 31, mit 68% (Stand: 21. August 2026).
- Wann wird FDA approves skin cancer vaccine by which date? entschieden?
- FDA approves skin cancer vaccine by which date? soll am 31. Dezember 2027 entschieden werden.
- Wie wird FDA approves skin cancer vaccine by which date? abgerechnet?
- Polymarket rechnet diesen Markt wie folgt ab: This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET.